IQVIA Holdings | IQV - Net Income


IQVIA Holdings reported $256M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Accenture USD 2.34B 513.75M Mar/2026
Agilent USD 339M 34M Mar/2026
Bruker USD -62.9M 66.4M Jun/2026
Cardinal Health USD 399M 68M Mar/2026
Celltrion KRW 8.82B 64.74M Mar/2026
Charles River Laboratories USD -1.48M 13.36M Jun/2026
Cigna USD 1.66B 6M Jun/2026
Cognizant Technology Solutions USD 636M 26M Jun/2026
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
CVS Health USD 2.98B 36M Jun/2026
Danaher USD 870M 159M Jun/2026
Dentsply International USD 37M 47M Jun/2026
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 9.02B 1.51B Jun/2026
Elevance Health USD 1.46B 301M Jun/2026
Humana USD 694M 492M Jun/2026
IBM USD 1.22B 4.38B Mar/2026
Illumina USD 207M 73M Jun/2026
Infosys INR 77.75B 7.34B Jun/2026
Kangmei Pharma CNY -16.56M 12.74M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Laboratory Of America USD 298.7M 20.9M Jun/2026
Malin Corporation EUR -1.1M 2.2M Dec/2023
McKesson USD 614M 1.07B Jun/2026
Mettler Toledo International USD 232.9M 63.44M Jun/2026
Organigram Holdings CAD -921K 20.89M Mar/2026
Ovoca Bio EUR 4.42M 5.19M Dec/2025
Pharma Mar EUR -972K 2.5M Jun/2026
Publicis EUR 793M 36M Jun/2026
Qiagen NV USD 68.04M 39.79M Mar/2026
Quest Diagnostics USD 320M 69M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
Sartorius EUR 65.9M 9.7M Jun/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Tilray USD -44.93M 44.61M Sep/2025
UnitedHealth USD 5.48B 796M Jun/2026
Veeva Systems USD 260.94M 16.73M Mar/2026
Veradigm USD -59.82M 74.35M Dec/2022
Waters USD -136M 64M Jun/2026
Zealand Pharma A/S -394M 14.88M Mar/2026
Zz Pientze Pharmaceu CNY 743.48M 56.45M Mar/2026